(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Cynthia Koons \u0010Health Care Reporter \u0010Bloomberg Editorial \u0010on Pfizer beating out rivals to buy biopharmaceutical company, Medivation, and its blockbuster cancer drug for $14 billion.

Nike Sees Weakness Persisting; US Decides Against Renewing USMCA
22:34

Chip Stocks’ Best Quarter Ever Is Ending With Some Wild Swings
22:33

Supreme Court Thwarts Trump Bid to Oust Fed’s Cook
20:43